Neonatal acute kidney injury – Severity and recovery prediction and the role of serum and urinary biomarkers. (February 2017)

• Record Type: Journal Article
• Authors: Sweetman, Deirdre U.
• Is Part Of: Early human development. Volume 105(2017)
• Page Start: 57
• Page End: 61
• Publication Date: 2017-02
• Subjects: Perinatal asphyxia -- Hypoxic ischaemic encephalopathy -- Cardiac surgery -- Sepsis -- Prematurity -- ECMO -- Nephrotoxicity -- NGAL -- Cystatin-C -- KIM-1 -- IL-18 -- Netrin-1 -- EGF; Fetus -- Periodicals; Neonatology -- Periodicals; Prenatal influences -- Periodicals; 612.65
• DOI: 10.1016/j.earlhumdev.2016.12.006
• Languages: English
• ISSNs: 0378-3782

Abstract

Abstract: Neonatal acute kidney injury is common, in part due to incomplete renal maturation and also due to frequent exposure to risk factors for acute kidney injury such as perinatal asphyxia, extracorporeal-membrane-oxygenation, cardiac surgery, sepsis, prematurity and nephrotoxicity. However the current method by which acute kidney injury is diagnosed is sub-optimal and not universally accepted which impairs the accurate estimation of the true incidence of neonatal acute kidney injury. Serum Cystatin-C, urinary NGAL, KIM-1 and IL-18 are promising neonatal acute kidney injury biomarkers however the diagnosis of acute kidney injury remains serum creatinine/urine output-based in many studies. Emerging biomarkers which require further study in the neonatal population include netrin-1 and EGF. Increased awareness amongst clinicians of nephrotoxic medications being a modifiable risk factor for the development of neonatal acute kidney injury is imperative. The burden of chronic kidney failure following neonatal acute kidney injury is unclear and requires further study.